67 related articles for article (PubMed ID: 32967862)
1. HPV Types in Cervical Precancer by HIV Status and Birth Region: A Population-Based Register Study.
Carlander C; Lagheden C; Eklund C; Nordqvist Kleppe S; Dzabic M; Wagner P; Yilmaz A; Elfgren K; Sönnerborg A; Sparén P; Dillner J
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2662-2668. PubMed ID: 32967862
[TBL] [Abstract][Full Text] [Related]
2. Nonvaccine human papillomavirus genotype common in women with HIV failing cervical precancer treatment.
Carlander C; Lagheden C; Eklund C; Nordqvist Kleppe S; Dzabic M; Wagner P; Sparén P; Dillner J
AIDS; 2021 Nov; 35(14):2367-2374. PubMed ID: 34723851
[TBL] [Abstract][Full Text] [Related]
3. Impact of immunosuppression and region of birth on risk of cervical intraepithelial neoplasia among migrants living with HIV in Sweden.
Carlander C; Wagner P; Svedhem V; Elfgren K; Westling K; Sönnerborg A; Sparén P
Int J Cancer; 2016 Oct; 139(7):1471-9. PubMed ID: 27177207
[TBL] [Abstract][Full Text] [Related]
4. HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study.
Gilles C; Rozenberg S; Buxant F; Manigart Y; de Wind R; Houte KV; Vandenbroeck D; Delforge M; Konopnicki D
Vaccine; 2022 Nov; 40(50):7230-7237. PubMed ID: 36328880
[TBL] [Abstract][Full Text] [Related]
5. Associations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa.
Kelly HA; Ngou J; Chikandiwa A; Sawadogo B; Gilham C; Omar T; Lompo O; Doutre S; Meda N; Weiss HA; Delany-Moretlwe S; Segondy M; Mayaud P;
PLoS One; 2017; 12(3):e0174117. PubMed ID: 28333966
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan.
Onuki M; Matsumoto K; Iwata T; Yamamoto K; Aoki Y; Maenohara S; Tsuda N; Kamiura S; Takehara K; Horie K; Tasaka N; Yahata H; Takei Y; Aoki Y; Kato H; Motohara T; Nakamura K; Ishikawa M; Kato T; Yoshida H; Matsumura N; Nakai H; Shigeta S; Takahashi F; Noda K; Yaegashi N; Yoshikawa H
Cancer Sci; 2020 Jul; 111(7):2546-2557. PubMed ID: 32372453
[TBL] [Abstract][Full Text] [Related]
7. High-risk human papillomavirus genotype distribution among women living with and at risk for HIV in Africa.
Chachage M; Parikh AP; Mahenge A; Bahemana E; Mnkai J; Mbuya W; Mcharo R; Maganga L; Mwamwaja J; Gervas R; Kibuuka H; Maswai J; Singoei V; Iroezindu M; Fasina A; Esber A; Dear N; Imbach M; Crowell TA; Hern J; Song X; Hoelscher M; Polyak CS; Ake JA; Geldmacher C;
AIDS; 2023 Mar; 37(4):625-635. PubMed ID: 36398743
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
9. Multiple High-Risk HPV Types Contribute to Cervical Dysplasia in Ugandan Women Living With HIV on Antiretroviral Therapy.
Nakisige C; Adams SV; Namirembe C; Okoche L; Ferrenberg J; Towlerton A; Larsen A; Orem J; Casper C; Frenkel L; Uldrick TS
J Acquir Immune Defic Syndr; 2022 Jul; 90(3):333-342. PubMed ID: 35195571
[TBL] [Abstract][Full Text] [Related]
10. Cervical human papillomavirus DNA detection in women living with HIV and HIV-uninfected women living in Limbe, Cameroon.
Adedimeji A; Ajeh R; Dzudie A; Kendowo E; Fuhngwa N; Nsame D; Simo-Wambo AG; Orock E; Hebert TM; Pierz AJ; Murokora D; Anastos K; Castle PE
J Clin Virol; 2020 Jul; 128():104445. PubMed ID: 32470891
[TBL] [Abstract][Full Text] [Related]
11. Suppressive antiretroviral therapy associates with effective treatment of high-grade cervical intraepithelial neoplasia.
Carlander C; Wagner P; van Beirs A; Yilmaz A; Elfgren K; Dillner J; Sönnerborg A; Sparén P
AIDS; 2018 Jul; 32(11):1475-1484. PubMed ID: 29746299
[TBL] [Abstract][Full Text] [Related]
12. HPV infection and pre-neoplastic cervical lesions among 321 HIV+ women in Florence, Italy, 2006-2016: prevalence and associated factors.
Fusco FM; Vichi F; Bisanzi S; Sani C; Degli Esposti A; Blè C; Rossi R; Pompeo G; Carozzi F; Blanc P
New Microbiol; 2018 Oct; 41(4):268-273. PubMed ID: 30252922
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus types in cervical high-grade lesions or cancer among Nordic women-Potential for prevention.
Dovey de la Cour C; Guleria S; Nygård M; Trygvadóttir L; Sigurdsson K; Liaw KL; Hortlund M; Lagheden C; Hansen BT; Munk C; Dillner J; Kjaer SK
Cancer Med; 2019 Feb; 8(2):839-849. PubMed ID: 30632704
[TBL] [Abstract][Full Text] [Related]
14. Methylation of High-Risk Human Papillomavirus Genomes Are Associated with Cervical Precancer in HIV-Positive Women.
Gradissimo A; Lam J; Attonito JD; Palefsky J; Massad LS; Xie X; Eltoum IE; Rahangdale L; Fischl MA; Anastos K; Minkoff H; Xue X; D'Souza G; Flowers LC; Colie C; Shrestha S; Hessol NA; Strickler HD; Burk RD
Cancer Epidemiol Biomarkers Prev; 2018 Dec; 27(12):1407-1415. PubMed ID: 30237251
[TBL] [Abstract][Full Text] [Related]
15. Long-term human papillomavirus vaccination effectiveness and immunity in Rwandan women living with and without HIV: a study protocol.
Murenzi G; Shumbusho F; Hansen N; Munyaneza A; Gage JC; Muhoza B; Kanyabwisha F; Pierz A; Tuyisenge P; Anastos K; Castle PE
BMJ Open; 2022 Aug; 12(8):e061650. PubMed ID: 36008069
[TBL] [Abstract][Full Text] [Related]
16. High-risk human papillomavirus prevalence in self-collected cervicovaginal specimens from human immunodeficiency virus (HIV)-negative women and women living with HIV living in Botswana.
Castle PE; Varallo JE; Bertram MM; Ratshaa B; Kitheka M; Rammipi K
PLoS One; 2020; 15(2):e0229086. PubMed ID: 32053659
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of cervical, oral, and anal human papillomavirus infection in women living with HIV in Denmark - The SHADE cohort study.
Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rönsholt FF; Johansen IS; Pedersen G; Gaardsting A; Nielsen LN; Bonde J; Lebech AM
J Clin Virol; 2018 Aug; 105():64-71. PubMed ID: 29906660
[TBL] [Abstract][Full Text] [Related]
18. Veteran Women Living With Human Immunodeficiency Virus Have Increased Risk of Human Papillomavirus (HPV)-Associated Genital Tract Cancers.
Clark E; Chen L; Dong Y; Raychaudhury S; White D; Kramer JR; Chiao E
Clin Infect Dis; 2021 May; 72(9):e359-e366. PubMed ID: 32785700
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
[TBL] [Abstract][Full Text] [Related]
20. Brief Report: Persistence of Non-Vaccine Oncogenic HPV Genotypes in Quadrivalent HPV-Vaccinated Women Living With HIV.
McClymont E; Coutlée F; Lee M; Albert A; Raboud J; Walmsley S; Lipsky N; Loutfy M; Trottier S; Smaill F; Klein MB; Yudin MH; Harris M; Wobeser W; Bitnun A; Samson L; Money D;
J Acquir Immune Defic Syndr; 2020 Mar; 83(3):230-234. PubMed ID: 31917750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]